To bolster its presence in India, Datwyler — the Swiss industrial supplier of high quality solutions for drug packaging and medical devices — has announced to complete expansion of its upcoming facility in Pune by the end of 2017 and aims to supply first samples in July 2018.
The expansion of 58,000 sq ft Pune facility, expected to create about 500 local jobs, incorporates First Line – the manufacturing concept for high-quality elastomer components, which will make India the first market in APAC region to incorporate this standard.
“The Indian market is of strategic value to Datwyler and our market share is quite substantial. We are currently supplying to the top 10 pharmaceutical companies and global players in the region. For this reason, we are expanding our presence in India. We invest in growth and believe it is one of the core strengths of the Indian market – and of Datwyler,” said Rahul Dev, Vice President India, Datwyler.
Set against the background of the ever-evolving requirements for drug packaging, Datwyler provides a unique range of future-proof healthcare sealing solutions and services for primary and secondary packaging.
In India, Datwyler’s core business consists of container closures. Manufacturing close to four billion components for vials, pre-filled syringes, and diagnostic devices per year, the Pune facility plays an increasingly strategic role for the company.